StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-18 | $0.62 | $0.53 | -14.84% | 0.0M |
| 05-19 | $0.54 | $0.59 | +9.30% | 0.1M |
| 05-20 | $0.55 | $0.57 | +4.49% | 0.0M |
| 05-21 | $0.58 | $0.55 | -6.84% | 0.0M |
| 05-22 | $0.51 | $0.51 | +0.20% | 0.0M |
Lakeside Holding Ltd i an integrated cross-border supply chain solution provider with a strategic focus on the Asian market including China and South Korea. It provides customized cross-border ocean freight solutions and airfreight solutions in the U.S, including cross-border freight consolidation and forwarding services; customs clearance services; warehousing and distribution services and U.S. domestic ground transportation services. It also operates a new business segment through, a comprehensive pharmaceutical distribution and supply chain service provider.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $13.11M | $6.10M | $17.79M | $11.48M |
Operating Income | $-2.76M | $-1.27M | $-4.96M | $-1.49M |
Net Income | $-2.94M | $-1.36M | $-5.25M | $-4.35M |
EPS (Diluted) | $-0.17 | $-0.09 | $-0.69 | $-0.58 |
Total Assets | $24.30M | $18.64M | $14.41M | $9.94M |
Total Liabilities | $12.12M | $11.68M | $11.56M | $9.19M |
Cash & Equivalents | $1.64M | $4.54M | $4.81M | $1.50M |
Free Cash Flow OCF − CapEx | Not available | Not available | $-2.70M | $-2.18M |
Shares Outstanding | 34.43M | 17.43M | 10.50M | 7.50M |
No sell-side coverage available for LSH yet.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
Latest Form 13F-HR disclosures from the curated Super Investors list. Click through to see each manager's full long book.